Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mitesco, Inc.MITI · Entity 8540 | Director · CEO and CFO | July 29, 2024 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mitesco, Inc.
Report date July 29, 2024 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,421,078 |
Ending reported balance
After 2026-08-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-07-29 · Grant · Acquired 200,000 · Balance 200,000 Row 2 · 2026-07-21 · Grant · Acquired 221,078 · Balance 421,078 Row 3 · 2026-08-03 · Grant · Acquired 3,000,000 · Balance 3,421,078 |
| Series X Pref.SEC Table II · derivative / convertible security | Direct | 2,400 |
Reported balance
After 2026-05-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-01 · Grant · Acquired 2,400 · Balance 2,400 F1: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. |
| Series X Pref.SEC Table II · derivative / convertible security | Direct | 7,200 |
Reported balance
After 2026-07-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-07-10 · Grant · Acquired 4,800 · Balance 7,200 F1: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 24, 2026 21:32 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantCommon Stock | 3,000,000 | $0.04 | $105,000.00 |
DisclosureSEC source: 0001185185-26-003695 · ownership.xml · nonDerivative · entry 3 Valania Brian · CIK 0002129239 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,421,078 Read SEC document |
| July 21, 2026 Filed Aug 24, 2026 21:32 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantCommon Stock | 221,078 | $0.08 | $17,686.24 |
DisclosureSEC source: 0001185185-26-003695 · ownership.xml · nonDerivative · entry 2 Valania Brian · CIK 0002129239 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 421,078 Read SEC document |
| July 10, 2026 Filed Aug 24, 2026 21:32 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantSeries X Pref. · Derivative | 4,800 | $400.00 | $1,920,000.00 |
DisclosureSEC source: 0001185185-26-003695 · ownership.xml · derivative · entry 5 Valania Brian · CIK 0002129239 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,200 Underlying: Common · 0 shares Expires not disclosed F1 · derivative.exercise_price: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. F1 · derivative.exercise_date: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. F1 · derivative.expiration_date: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. Read SEC document |
| May 01, 2026 Filed Aug 24, 2026 21:32 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantSeries X Pref. · Derivative | 2,400 | $400.00 | $960,000.00 |
DisclosureSEC source: 0001185185-26-003695 · ownership.xml · derivative · entry 4 Valania Brian · CIK 0002129239 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,400 Underlying: Common · 0 shares Expires not disclosed F1 · derivative.exercise_price: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. F1 · derivative.exercise_date: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. F1 · derivative.expiration_date: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it. Read SEC document |
| July 29, 2024 Filed Aug 24, 2026 21:32 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantCommon Stock | 200,000 | $0.25 | $50,000.00 |
DisclosureSEC source: 0001185185-26-003695 · ownership.xml · nonDerivative · entry 1 Valania Brian · CIK 0002129239 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.